High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
Year: 1992
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institutions: Université Libre de Bruxelles, Institut Jules Bordet
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W1889451488
